Oxford Nanopore Receives Regulatory Approval for its First Diagnostic Device in the UK and Europe

Oxford Nanopore Technologies has received regulatory approval for its first diagnostic device, GridION Dx, in the UK and Europe. The CE and UKCA certification confirms that GridION Dx meets international standards for quality, safety, and performance. Initially, GridION Dx will be available through specified partnerships, with the first application being infectious disease characterization. The company aims to expand its sequencing-based diagnostics to oncology and genetic conditions in the future.